Annie Collier is a Principal Scientist and Biomarker Lead in Translational Medicine Oncology at Genentech, where they focus on advancing technology to detect cellular signaling biomarkers. Annie holds a PhD in Biochemistry and Molecular Biology from Indiana University School of Medicine and has extensive research experience, including a postdoctoral role at Stanford University. Additionally, they began their journey in the field with a Bachelor of Arts in Biochemistry from DePauw University and completed a pediatric research internship at Indiana University Health.
Location
San Francisco, United States